{{Rsnum
|rsid=11919783
|Gene=GSK3B
|Chromosome=3
|position=120027786
|Orientation=plus
|GMAF=0.06749
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GSK3B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 31.9 | 67.3
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 4.8 | 95.2
| ASW | 1.8 | 12.3 | 86.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 12.9 | 87.1
| LWK | 0.0 | 8.3 | 91.7
| MEX | 1.7 | 13.8 | 84.5
| MKK | 0.0 | 9.0 | 91.0
| TSI | 1.0 | 32.4 | 66.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=20605420
|Title=Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}